MED Q2'26 Earnings: EPS estimate is (0.65) USD
Medifast Inc. (MED) is scheduled to report Q2 2026 earnings on Aug. 3 after the market closes, with results expected at 4:05 PM ET. The consensus estimates call for revenue of $72.70 million and EPS of -$0.65 for the quarter, according to the article.
How this was made
The 30-second read
Why it matters
Traders can use the consensus revenue ($72.70M) and EPS (-$0.65) to frame expectations and manage event risk into the after-hours release.
Market read
The article is a scheduled earnings preview with consensus estimates, useful for event-risk positioning ahead of the print.
What to watch
Actual results could hinge on margin and subscriber retention trends, which are not discussed in the article, so consensus alone may not capture the key drivers.
Background
MEDIFAST (MED) is set to announce Q2'26 earnings on Aug 03 after the market closes.
Ticker impact
MEDIFAST is scheduled to report Q2'26 results Aug 03 after the close, with consensus revenue of $72.70M and EPS of -$0.65.
Likely volatility around the Aug 03 after-hours earnings release versus the -$0.65 EPS and $72.70M revenue expectations.
The article provides only the scheduled earnings date and consensus estimates, with no new guidance, results, or surprises disclosed yet.
Market effects
Limited spillover; this is company-specific pre-earnings positioning for a diet/weight-management retailer.
None indicated.
None indicated.
Counterpoint
If the company has a history of beating or guiding conservatively, the negative EPS consensus may already be priced in, reducing incremental downside risk.
Key entities
- public_companyMED
MEDIFAST Inc., scheduled to report Q2'26 results on Aug 03 after the close.
